MSB 3.13% 99.0¢ mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-204

  1. 143 Posts.
    lightbulb Created with Sketch. 16
    @stockrock - many thanks for your fantastic posts.

    I have been badly burned by the SP impact of the FDA CRL yesterday

    How sure are you in saying the CRL is a Class 2? The Mesoblast announcement doesn’t say FDA requested a pre or post approval additional clinical trial

    Thanks in advance
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢
Change
0.030(3.13%)
Mkt cap ! $1.130B
Open High Low Value Volume
96.5¢ $1.03 96.5¢ $4.704M 4.708M

Buyers (Bids)

No. Vol. Price($)
6 87395 98.5¢
 

Sellers (Offers)

Price($) Vol. No.
$1.00 274051 2
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.